Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

2010274 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov unique identifier: NCT00633490.

Good health and well-being

Published in: BMC Cancer

Volume 10, Issue 1, pp. 529-529

Field-Weighted Citation Impact: 1.62